Clinical trials
Phase 2 Diabetic Nephropathies trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Tanabe Pharma Corporation | 2 |
| AbbVie (prior sponsor, Abbott) | 1 |
| Bayer | 1 |
| Boehringer Ingelheim | 1 |
| Daiichi Sankyo | 1 |
| Daiichi Sankyo Co., Ltd. | 1 |
| Eli Lilly and Company | 1 |
| Gilead Sciences | 1 |
| Kyowa Kirin Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Nephropathies | 15 |
| Renal Insufficiency, Chronic | 5 |
| Diabetes Mellitus, Type 2 | 3 |
| Diabetes Mellitus | 2 |
| Proteinuria | 2 |
| Diabetes Complications | 1 |
| Endocrine System Diseases | 1 |
| Glucose Metabolism Disorders | 1 |
| Heart Failure | 1 |
| Kidney Diseases | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.